mpagliflozin is an SGLT2 inhibitor, a drug class which helps to stop sodium-glucose transport proteins that have been filtered out of the blood by the kidneys being reabsorbed back into the blood. Empagliflozin allows a significant amount of sugar to be removed through urination.